Soft intraocular lens material and soft intraocular lens
By using a combination of aromatic ring-containing methacrylates and alkoxyacrylates in soft intraocular lens materials, the problems of insufficient flare and flexibility in existing materials are solved, achieving both efficient flare suppression and flexibility, making them suitable for the folding and restoration of intraocular lenses.
Patent Information
- Application Number
- CN202211547679.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2018-12-28
- Filing Date
- 2019-12-26
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2039-12-26
AI Technical Summary
Existing soft intraocular lens materials have shortcomings in balancing flexibility, shape recovery, and reduction of flare. In particular, hydrophobic acrylates have poor affinity for water, leading to frequent occurrences of water condensation and punctate flare within the lens.
The main components are methacrylates containing aromatic rings and alkoxyacrylates without aromatic rings. By using them in combination, a polymer skeleton is formed to suppress flash, while taking into account both softness and shape recovery. The ratio of hydrophilic and crosslinking monomers is appropriately controlled.
This technology significantly reduces scintillation without compromising flexibility, improves the biocompatibility and operability of the lens, and is suitable for soft intraocular lens materials that can be folded and restored to their original shape.
Smart Images

Figure CN115975105B_ABST
Abstract
Description
[0001] This case is filed on December 26, 2019 、Application number is 201980082920.3 (PCT / JP2019 / 051262) , divisional application entitled "Soft intraocular lens material and soft intraocular lens". Technical Field
[0002] The present invention relates to a soft intraocular lens material and a soft intraocular lens.
[0003] The present invention claims priority based on International Application No. PCT / JP2018 / 048610 filed on December 28, 2018, the entire contents of which are incorporated herein by reference. Background Art
[0004] As one of the treatment methods for cataracts, a method of removing the white turbid lens from the lens capsule and inserting an intraocular lens (artificial lens, Intraocular Lens: IOL) that replaces the lens and takes on the refractive power into the capsule has been widely used. The intraocular lens includes an optical part that exerts the refractive power and a support part that fixes the position of the optical part in the capsule. When inserting the intraocular lens, for example, a one-piece intraocular lens formed by the optical part and the support part is prepared, and the intraocular lens is inserted into the eye in a folded state using an insertion device called an injector. The inserted intraocular lens returns to its original shape in the capsule, and the support part presses against the capsule to stabilize its position in the capsule. In order to make the incision of the lens capsule as small as possible, it is expected that the intraocular lens has high flexibility and shape recovery (for example, refer to patent documents 1 to 3).
[0005] Prior art literature
[0006] Patent Literature
[0007] Patent Document 1: International Publication No. 2018 / 021455
[0008] Patent Document 2: Japanese Patent Application Publication No. 56998, Heisei 11
[0009] Patent Document 3: International Publication No. 2016 / 121804 Summary of the invention
[0010] Technical problem to be solved by the invention
[0011] As the constituent materials of such foldable soft intraocular lenses, soft resins including silicone, hydrophobic (meth)acrylates and hydrophilic (meth)acrylates are widely used. Among them, hydrophobic (meth)acrylates are widely used because there are few cases of postoperative cataracts. However, hydrophobic (meth)acrylates have poor affinity with water and are prone to the phenomenon called glistening, that is, a small amount of water in the lens condenses into dots and looks shiny. Therefore, when making soft intraocular lens materials, hydrophobic (meth)acrylates and hydrophilic (meth)acrylates must be used at the same time. However, in existing soft intraocular lens materials, there is still room for improvement in terms of balancing the above-mentioned softness and shape recovery with the reduction of glare. Moreover, there is also a potential demand for a variety of soft intraocular lens materials that can balance these characteristics.
[0012] In view of the above-mentioned prior art, an object of the present invention is to provide a new soft intraocular lens material that has both flexibility and shape recovery and reduced flare. In addition, from another viewpoint, an object of the present invention is to provide a soft intraocular lens using the soft intraocular lens material.
[0013] Technical solutions for solving technical problems
[0014] The soft intraocular lens material provided by the technology disclosed herein is obtained by polymerizing a polymerizable polymer component, wherein the polymer component comprises an aromatic ring-containing methacrylate (A), an alkoxy-containing acrylate (B), a hydroxyl-containing acrylate (C) and a crosslinkable (meth)acrylate (D). When the polymer component is 100 parts by mass, the alkoxy-containing acrylate (B) is 30 parts by mass or more.
[0015] The inventors of the present invention have conducted detailed verification of existing soft intraocular lens materials, and have confirmed the following. That is, in order to suppress the occurrence of flare, the existing soft intraocular lens materials contain sufficient hydrophilic (meth)acrylates. However, the hydrophilic (meth)acrylates can suppress the occurrence of flare by creating an environment in which aqueous humor is not easily condensed in the gaps of the polymer, but have the negative effect of increasing the hardness of the polymer. In addition, when the hydrophilicity of the soft intraocular lens material increases, it absorbs moisture in the air, which makes the shape and physical properties of the lens easily change, thereby making the operability of the intraocular lens difficult. In addition, although there are monomer components in hydrophobic (meth)acrylates that can suppress the occurrence of flare, such as the well-known polymethyl methacrylate (PMMA), the polymer obtained using such monomer components is a hard material to the extent that it cannot be folded when forming a lens, and is therefore difficult to use.
[0016] Therefore, the inventors of the present invention have made intensive studies and found that, by using a methacrylate monomer having an aromatic ring and an alkoxy acrylate having no aromatic ring in combination, it is possible to exhibit a flare suppression effect without impairing the flexibility and shape recovery (hereinafter, sometimes referred to as "physical properties") suitable for a soft intraocular lens material, and to replace part of the function of the hydrophilic monomer, thereby completing the present invention. However, from the perspective of ensuring sufficient flexibility, it is important to contain 30 parts by mass or more of an alkoxy-containing acrylate (B) that is softer than the methacrylate component. Thus, a soft intraocular lens material that achieves both flexibility and shape recovery and flare reduction can be provided.
[0017] In a preferred embodiment of the soft intraocular lens material disclosed herein, the amount of the aromatic ring-containing methacrylate (A) is 40 to 52 parts by mass based on 100 parts by mass of the polymerizable components. With such a configuration, the occurrence of flare can be well suppressed without impairing the flexibility suitable for folding of the soft intraocular lens material.
[0018] In a preferred embodiment of the soft intraocular lens material disclosed herein, the alkoxy-containing acrylate (B) is 35 to 46 parts by mass based on 100 parts by mass of the polymerizable component. With such a configuration, flexibility, shape recovery, and flare reduction can be well balanced.
[0019] In a preferred embodiment of the soft intraocular lens material disclosed herein, the hydroxyl-containing acrylate (C) is in an amount of 8 parts by mass to 12 parts by mass based on 100 parts by mass of the polymerizable component. By suppressing the use of the hydrophilic acrylate to such a small amount, the decrease in the flexibility and shape recovery of the soft intraocular lens can be more effectively reduced.
[0020] In a preferred embodiment of the soft intraocular lens material disclosed herein, the total amount of the aromatic ring-containing methacrylate (A) and the alkoxy group-containing acrylate (B) is 75 parts by mass or more and 90 parts by mass or less, based on 100 parts by mass of the polymerized components. According to the soft intraocular lens material disclosed herein, it is believed that a polymer having a skeleton effective for reducing flare is formed by combining the aromatic ring-containing methacrylate and the aromatic ring-free alkoxy acrylate. As a result, flare can be reduced while suppressing the presence of a hard hydrophilic (meth)acrylate, and the physical properties and flare reduction can be balanced at a high level.
[0021] In a preferred embodiment of the soft intraocular lens material disclosed herein, the aromatic ring-containing methacrylate (A) contains a methacrylate represented by the following general formula (1):
[0022]
[0023] In the formula, R1 represents a linear or branched alkylene group having 1 to 8 carbon atoms, and X represents an absent element or an oxygen atom. Thus, the high refractive index and flexibility of the soft intraocular lens material can be achieved while further improving the above effects.
[0024] In a preferred embodiment of the soft intraocular lens material disclosed herein, the alkoxy-containing acrylate (B) comprises an acrylate represented by the following general formula (2):
[0025]
[0026] In the formula, R2 is a methyl group or an ethyl group, and n is an integer of 1 to 4. Thus, the above-mentioned effects can be further improved.
[0027] In a preferred embodiment of the soft intraocular lens material disclosed herein, the hydroxyl-containing acrylate (C) comprises an acrylate represented by the following general formula (3):
[0028]
[0029] In the formula, R3 is a linear or branched alkylene group having 1 to 8 carbon atoms. This can further enhance the above-mentioned effect.
[0030] In a preferred embodiment of the soft intraocular lens material disclosed herein, the polymerizable component contains a monomer having ultraviolet light absorbing ability. Thus, a soft intraocular lens capable of reducing the risk of eye diseases caused by ultraviolet light is provided.
[0031] In a preferred embodiment of the soft intraocular lens material disclosed herein, the polymerizable component contains a monomer having yellow coloring ability, thereby suppressing the transmission of a portion of blue light and providing natural vision that is no different from vision through the crystalline lens.
[0032] The above soft intraocular lens material has excellent flexibility and flare suppression effect. Such characteristics are particularly suitable when used as a material for a soft intraocular lens that is kept immersed in aqueous humor for a long time after being implanted in the eyeball. Therefore, in another aspect, the technology disclosed herein also provides a soft intraocular lens made using any of the above soft intraocular lens materials. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Figure 1 (a) is a plan view and (b) is a side view schematically illustrating the structure of a single-piece intraocular lens according to one embodiment.
[0034] Explanation of symbols
[0035] 1: intraocular lens; 10: optical part; 20: support part; 20a: bending part. DETAILED DESCRIPTION
[0036] The preferred embodiment of the present invention is described below. In addition, with respect to matters other than matters specifically mentioned in this specification (composition of soft intraocular lens, etc.) and matters necessary for implementing the present invention (basic form of soft intraocular lens, etc.), those skilled in the art can understand based on the teachings on implementing the invention described in this specification and the technical common sense at the time of application. The present invention can be implemented based on the contents disclosed in this specification and the technical common sense in this field. Moreover, in the following drawings, parts and portions having the same function are sometimes described with the same symbols, and repeated descriptions are sometimes omitted or simplified. In addition, expressions such as "A to B" indicating a numerical range, unless otherwise specified, mean "A or more and B or less".
[0037] Figure 1 It is a diagram for explaining the structure of a single-piece soft intraocular lens according to one embodiment. Figure 1 (a) is a top view, and (b) is a side view. The soft intraocular lens 1 includes an optical portion 10 having a predetermined refractive power and a pair of support portions 20 for supporting the optical portion 10 in the eye. The optical portion 10 and the support portion 20 are integrally molded from the same raw resin composition.
[0038] The optical part 10 has, for example, a circular shape with a diameter D of about 5.5 mm to 7 mm, typically about 6 mm, when viewed from above. The direction orthogonal to the diameter D direction of the optical part 10 is called the thickness direction. In addition, when viewed from the side, the optical part 10 has, for example, a biconvex lens shape protruding toward both sides (both sides of the thickness direction). The thickness of the optical part 10 can be determined based on the refractive index of the material constituting the optical part 10, the desired refractive power required for the optical part 10, etc. Regarding the thickness of the optical part 10, at the center O of the circular optical part 10, for example, it is 300 μm or more, and as an example, it can be 400 μm or more. In addition, the thickness of the optical part 10 is, for example, about 1000 μm or less, for example, 900 μm or less, as an example, 700 μm or less, and can be about 600 μm (about ±10%). However, the shape of the optical part 10 is not limited thereto. The shape of the optical part 10 can be, for example, elliptical or quasi-elliptical when viewed from above. The shape of the optical portion 10 may be, for example, a plano-convex lens shape in which only one surface is protruding and the other surface is flat when viewed from the side, or a convex meniscus lens shape in which one surface is protruding and the other surface is concave.
[0039] The support portion 20 is formed to protrude outward from the periphery of the optical portion 10. With respect to the optical portion 10, a pair of support portions 20 are formed to be point symmetrical with the center O of the optical portion 10 as the axis of symmetry. The support portion 20 is in the shape of a loop with one end being a free end. The support portion 20 has a curved portion 20a that is greatly curved in the plane of the lens portion near the connection portion with the optical portion 10. The support portion 20 is configured so that the curved portion 20a can be further bent in a direction that brings the free end portion closer to the center O. The distance L between the free ends of the pair of support portions 20 is, for example, about 11.5 mm to 13.5 mm, and typically about 12 mm to 13 mm. However, the shape of the support portion 20 is not limited thereto. The optical portion 10 and the support portion 20 may be made of the same material or different materials. With respect to the soft intraocular lens 1 disclosed herein, for example, the optical portion 10 and the support portion 20 may be made of the same soft intraocular lens material.
[0040] The soft intraocular lens material is formed by polymerizing a polymerizable polymer component. The polymer component used to form the soft intraocular lens material essentially contains an aromatic ring-containing methacrylate (A), an alkoxy-containing acrylate (B), a hydroxyl-containing acrylate (C), and a crosslinkable (meth)acrylate (D). In other words, the soft intraocular lens material is composed of a (meth)acrylate copolymer containing a monomer unit corresponding to the aromatic ring-containing methacrylate (A), a monomer unit corresponding to the alkoxy-containing acrylate (B), a monomer unit corresponding to the hydroxyl-containing acrylate (C), and a monomer unit corresponding to the crosslinkable (meth)acrylate (D).
[0041] In addition, in this specification, "(meth)acrylate copolymer" is a polymer collectively referred to as a so-called "acrylic polymer", which refers to a polymer containing monomer units derived from the following monomers (hereinafter, sometimes referred to as (meth)acrylate monomers). The above monomers are monomers having at least one (meth)acryloyl group containing a polymerizable unsaturated double bond in one molecular structure. (Meth)acrylate copolymers are typically polymers containing monomer units derived from (meth)acrylate monomers in a molecular structure in a total ratio of 50% by mass or more (preferably 75% by mass or more, more preferably 80% by mass or more, particularly preferably 90% by mass or more, for example 95% by mass or more). In addition, "(meth)acrylate" is a term that includes the meaning of acrylate and methacrylate. Below, each polymerization component is explained.
[0042] The inventors of the present invention have found that when an aromatic ring-containing methacrylate (A) and an alkoxy-containing acrylate (B) are used simultaneously, it has the effect of being able to take into account both appropriate physical properties and flare suppression at a high level. In other words, the synergistic effect of the aromatic ring-containing methacrylate monomer (A) and the alkoxy-containing acrylate (B) helps to take into account both appropriate physical properties and flare suppression effects. Although the details of this mechanism are not yet clear, according to the inventors of the present invention so far, it has been found that the methacrylate-based polymer components can exist at a relatively high concentration near the surface of the polymer compared to the acrylate-based polymer components (for example, refer to International Publication No. 2019 / 138952). In addition, it is believed that even polymers generally referred to as hydrophobic acrylic polymers, although at a level of less than 1%, are mostly water-absorbent, and in conventional intraocular lenses, flare is generated based on this small amount of water absorption. In contrast, when the aromatic ring-containing methacrylate (A) disclosed here is polymerized at a high concentration, it can exert high hydrophobicity similar to PMMA. Therefore, it is believed that the aromatic ring-containing methacrylate (A) is polymerized at a high concentration near the surface to form a hydrophobic surface, which helps to effectively reduce flare. It is also believed that the hydrophilic alkoxy-containing acrylate (B) and hydroxyl-containing acrylate (C) can be present at a relatively high concentration near the center of the polymer, thereby suppressing the reduction of flare on the polymer surface and imparting good flexibility and shape recovery to the polymer.
[0043] As the polymerizable aromatic ring-containing methacrylate (A), a compound containing at least one aromatic hydrocarbon group in its structure can be used. The methacrylate monomer containing an aromatic ring gives the polymer a function of increasing the refractive index of the intraocular lens. As the aromatic hydrocarbon group, a benzene ring, a naphthalene ring, a biphenyl ring, a heterocyclic ring, etc. can be listed. As the heterocyclic ring, a morpholine ring, a piperidine ring, a pyrrolidine ring, a piperazine ring, etc. can be listed. Examples of the methacrylic acid monomer containing an aromatic ring include, for example, benzyl methacrylate, phenyl methacrylate, o-phenylphenol methacrylate, phenoxy methacrylate, ethylene glycol phenyl ether methacrylate, diethylene glycol phenyl ether methacrylate, propylene glycol phenyl ether methacrylate, ethylene oxide-modified nonylphenol methacrylate, ethylene oxide-modified cresol methacrylate, phenol ethylene oxide-modified methacrylate, methacrylate-2-hydroxy-3-phenoxypropyl, methoxybenzyl methacrylate, chlorobenzyl methacrylate, methacrylate-cresol, polystyrene methacrylate, and other monomers having a benzene ring; hydroxyethylated β-naphthol methacrylate, methacrylate-2-naphthylethyl ester, methacrylate-2-(4-methoxy-1-naphthyloxy)ethyl ester, and other monomers having a biphenyl ring; biphenyl methacrylate and other monomers having a biphenyl ring. These methacrylic acid ester monomers containing an aromatic ring may be contained alone or in combination of two or more. The proportion of the polymerizable aromatic ring-containing methacrylate monomer in the (meth)acrylate copolymer may be, for example, about 35 parts by mass or more, preferably about 40 parts by mass or more, and may be, for example, about 42 parts by mass or more, when the total of the four polymer components (A) to (D) is 100 parts by mass, but is not limited thereto. The proportion of the aromatic ring-containing methacrylate monomer (A) may be, for example, about 55 parts by mass or less, preferably 52 parts by mass or less, and may be, for example, about 50 parts by mass or less.
[0044] However, it is known that polymers containing units derived from aromatic ring-containing methacrylate monomers tend to have higher hardness due to the large structure of the aromatic ring. Therefore, the aromatic ring-containing (meth)acrylic monomer is more preferably a methacrylate monomer having a relatively low glass transition temperature. As such an aromatic ring-containing methacrylate (A), a methacrylate monomer represented by the following general formula (1) is preferred.
[0045]
[0046] Among them, in the formula, R1 represents a linear or branched alkylene group having 1 to 8 carbon atoms, and X represents the absence of an element (i.e., a single bond) or an oxygen atom. As an alkylene group, for example, specifically, it can be a methylene group, an ethylene group, a n-propylene group, an isopropylene group, a cyclopropylene group, a n-butylene group, an isobutylene group, a sec-butylene group, a tert-butylene group, a cyclobutylene group, a n-pentylene group, a 1-methyl-n-butylene group, a 2-methyl-n-butylene group, a 3-methyl-n-butylene group, a 1,1-dimethyl-n-propylene group, a 1,2-dimethyl-n-propylene group, a 2,2-dimethyl-n-propylene group, a 1-ethyl-n-propylene group, a cyclopentylene group, a n-hexylene group, etc. From the viewpoint of reducing the water absorption of the polymer, X is more preferably a single bond. Preferred examples of such methacrylate monomer components include benzyl methacrylate, phenylethyl methacrylate, ethylene glycol monophenyl ether methacrylate, diethylene glycol monophenyl ether methacrylate, and tetraethylene glycol monophenyl ether methacrylate.
[0047] The alkoxy-containing acrylate (B) is, for example, an acrylate monomer component represented by the following formula: CH2=CHCOOR2, wherein R2 is a monomer containing an alkoxy functional group and / or a substituent in at least a portion. The alkoxy group may be, for example, a monomer having 1 to 5 carbon atoms (hereinafter, simply represented by "C 1-5 ".) or C 1-4 , typically an alkoxy group of C1, C2, C3, etc. Specifically, there can be mentioned a methoxy group, an ethoxy group, a propoxy group, a tert-butoxy group, a pentyloxy group, an allyloxy group, etc., and functional groups partially containing these.
[0048] As such alkoxy-containing acrylates, for example, specifically, ethylene glycol monomethyl ether acrylate, ethylene glycol monoethyl ether acrylate, ethylene glycol monobutyl acrylate, diethylene glycol monomethyl ether acrylate, diethylene glycol monoethyl ether acrylate, diethylene glycol monobutyl ether acrylate, dipropylene glycol methyl ether acrylate, dipropylene glycol ethyl ether acrylate, triethylene glycol monomethyl ether acrylate, triethylene glycol monoethyl ether acrylate, tetraethylene glycol monomethyl ether acrylate, tetraethylene glycol monoethyl ether acrylate, polyethylene glycol monomethyl ether acrylate, polyethylene glycol monoethyl ether acrylate, 2-(2-ethylhexyloxy)ethyl acrylate and the like can be cited. The alkoxy-containing acrylate (B) preferably contains, for example, an acrylate represented by the following general formula (2).
[0049]
[0050] Wherein, R2 is a methyl group or an ethyl group, and n is an integer of 1 to 4. As an example of such a compound, ethoxy monomethyl ether acrylate containing 1 to 4 ethoxy groups, ethoxy monoethyl ether acrylate containing 1 to 4 ethoxy groups, etc. can be listed. Among them, ethylene glycol monomethyl ether acrylate (2-methoxyethyl acrylate: MEA), ethylene glycol monoethyl ether acrylate (2-ethoxyethyl acrylate: EEA), diethylene glycol monomethyl ether acrylate (2-(2-ethoxyethoxy)methyl-acrylate: EEMA), and diethylene glycol monoethyl ether acrylate (2-(2-ethoxyethoxy)ethyl acrylate: EEEA) are preferably used. Any one of these may be contained alone, or two or more may be contained in combination. The proportion of the alkoxy-containing acrylate (B) in the polymerization component, for example, when the total of the four polymerization components (A) to (D) mentioned above is set to 100 parts by mass, can be about 30 parts by mass or more, preferably about 35 parts by mass or more, for example, about 38 parts by mass or more. The proportion of the alkoxy-containing acrylate (B) may be, for example, approximately 50 parts by mass or less, preferably 46 parts by mass or less, and for example, approximately 40 parts by mass or less.
[0051] The hydroxyl-containing acrylate (C) can increase the hydrophilicity of the (meth)acrylate copolymer, create an environment in which aqueous humor is difficult to aggregate in the gaps of the copolymer, and has a function of suppressing the occurrence of flare. The hydroxyl-containing acrylate (C) preferably contains a compound represented by the following general formula (3).
[0052]
[0053] Among them, in the formula, R3 is a linear or branched alkylene group having 1 to 8 carbon atoms. As an example of such a polymer component, 2-hydroxyethyl acrylate, 2-hydroxypropyl acrylate, 4-hydroxybutyl acrylate, 6-hydroxyhexyl acrylate, 2,3-dihydroxypropyl acrylate, 8-hydroxyoctyl acrylate, etc. can be listed. Among them, 2-hydroxyethyl acrylate (HEA), 4-hydroxybutyl acrylate (HBA), etc. are preferably used. These can contain any one alone, or two or more can be contained in combination.
[0054] The proportion of the hydroxyl-containing acrylate (C) in the (meth)acrylate copolymer is not strictly limited. For example, from the viewpoint of better suppressing the flare of the intraocular lens, when the total of the above-mentioned four polymer components (A) to (D) is set to 100 parts by mass, the proportion of the hydroxyl-containing acrylate (C) can be, for example, about 5 parts by mass or more, preferably about 8 parts by mass or more, for example, about 9 parts by mass or more. However, in the technology disclosed herein, in order to enable the above-mentioned aromatic ring-containing methacrylate monomer (A) and alkoxy-containing acrylate (B) to suppress the occurrence of flare under more moderate conditions, it is preferred that the proportion of the hydroxyl-containing acrylate (C) that greatly affects the physical properties such as the shape and water content of the intraocular lens is small. From this viewpoint, the proportion of the hydroxyl-containing acrylate (C) can be, for example, about 15 parts by mass or less (less than 15 parts by mass), preferably 12 parts by mass or less or 11.5 parts by mass or less, for example, about 11 parts by mass or less.
[0055] As the cross-linkable (meth)acrylate (D), a difunctional (meth)acrylate or a trifunctional or higher polyfunctional (meth)acrylate may be used. In general polymer design, trifunctional to hexafunctional monomers are widely used for the purpose of introducing cross-linking points. However, the more functional groups there are, the higher the hardness of the polymer can become. When introducing cross-linking points into a soft intraocular lens material, it is preferred to use a difunctional or trifunctional (meth)acrylate because it is required to have appropriate hardness and high flexibility. In addition, the cross-linkable (meth)acrylate (D) may not contain a tetrafunctional or higher polyfunctional (meth)acrylate.
[0056] Examples of such bifunctional (meth)acrylates include, for example, 1,3-butylene glycol di(meth)acrylate, 1,4-butylene glycol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, 1,9-nonanediol di(meth)acrylate, 1,10-decanediol di(meth)acrylate, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, tetramethylene glycol di(meth)acrylate, ethylene oxide-modified bisphenol A di(meth)acrylate, propylene glycol di(meth)acrylate, dipropylene glycol di(meth)acrylate, tripropylene glycol di(meth)acrylate, etc. Examples of such trifunctional (meth)acrylates include, for example, trimethylolpropane tri(meth)acrylate, tris(2-acryloyloxyethyl)isocyanurate, and ethylene oxide-modified trimethylolpropane tri(meth)acrylate. Among them, any one of 1,3-butanediol di(meth)acrylate, 1,4-butanediol di(meth)acrylate, and 1,6-hexanediol di(meth)acrylate is preferably used. In addition, when the total amount of the crosslinkable (meth)acrylate (D) is 100% by mass, the crosslinkable acrylic monomer component is preferably about 50% by mass or more, more preferably about 60% by mass or more, for example, about 70% by mass or more, about 80% by mass or more, preferably about 90% by mass or more, and for example, it can be substantially 100% by mass, but it is not limited thereto. Thereby, the physical properties of the soft intraocular lens material can be stably improved.
[0057] The proportion of the cross-linkable (meth)acrylate (D) in the (meth)acrylate copolymer is not strictly limited. For example, from the viewpoint of better suppressing the flare of the soft intraocular lens, when the total of the above-mentioned four polymer components (A) to (D) is set to 100 parts by mass, the proportion of the cross-linkable (meth)acrylate (D) is, for example, about 1 part by mass or more, preferably about 3 parts by mass or more, for example, about 4 parts by mass or more. However, when the amount of the cross-linkable (meth)acrylate (D) becomes excessive, the hardness of the soft intraocular lens material may become too high, which is not preferred. From this aspect, the proportion of the cross-linkable (meth)acrylate (D) can be 10 parts by mass or less, preferably 10 parts by mass or less, more preferably 8 parts by mass or less, for example, 5 parts by mass or less.
[0058] The total molar number M of the aromatic ring-containing methacrylate (A), alkoxy-containing acrylate (B), hydroxyl-containing acrylate (C) and crosslinkable (meth)acrylate (D) relative to the acrylic monomer is A The total number of moles of methacrylic acid monomers M M Set to M M / M A Although not limited to this, MM / M A The value of is preferably 0.2 or more, more preferably 0.4 or more, for example, 0.5 or more. M / M A The value of is preferably 1.2 or less, more preferably 1.1 or less, and for example may be 1 or less.
[0059] In addition, from the viewpoint of better exerting the combined effect of the aromatic ring-containing methacrylate (A) and the alkoxy-containing acrylate (B), when the total of the four polymer components (A) to (D) is 100 parts by mass, the total amount of the aromatic ring-containing methacrylate (A) and the alkoxy-containing acrylate (B) can be 75 parts by mass or more, preferably 80 parts by mass or more, and can also be 81 parts by mass or more, 82 parts by mass or more, 83 parts by mass or more, or 85 parts by mass or more. In other words, the total amount of the hydroxyl-containing acrylate (C) and the crosslinkable (meth)acrylate (D) can be 25 parts by mass or less, preferably 20 parts by mass or less, and can also be 19 parts by mass or less, 18 parts by mass or less, 17 parts by mass or less, or 15 parts by mass or less.
[0060] However, considering the presence of a hydrophilic monomer component and a crosslinking monomer component, the total amount of the aromatic ring-containing methacrylate (A) and the alkoxy-containing acrylate (B) is preferably controlled to be 90 parts by mass or less, for example, 89 parts by mass or less, or 88 parts by mass or less. In other words, the total amount of the hydroxyl-containing acrylate (C) and the crosslinking (meth)acrylate (D) may be 10 parts by mass or more, for example, 11 parts by mass or more, or 12 parts by mass or more. Thus, a soft intraocular lens having both high-level physical properties and low-glare properties can be realized by a soft intraocular lens material having a simpler structure.
[0061] Furthermore, the (meth)acrylate copolymer constituting the soft intraocular lens material may contain polymerization components corresponding to structural units other than those described above, within the range not impairing the essence of the technology disclosed herein.
[0062] As other polymer components, for example, aromatic ring-containing acrylates, alkoxy-containing methacrylates and hydroxyl-containing methacrylates corresponding to the above-mentioned aromatic ring-containing methacrylates (A), alkoxy-containing acrylates (B) and hydroxyl-containing acrylates (C) can be used. However, since these polymer components will damage the balance of the above-mentioned polymer components (A) to (C), it is preferred that the proportion of the corresponding aromatic ring-containing methacrylates (A), alkoxy-containing acrylates (B) and hydroxyl-containing acrylates (C) is 10% by mass or less, preferably 5% by mass or less, for example, 3% by mass or less. It is preferred that the composition does not contain aromatic ring-containing acrylates, alkoxy-containing methacrylates and hydroxyl-containing methacrylates.
[0063] In addition, as other polymer components, for example, the following formula can be cited: CH2=C(R 1 )COOR 2 The monomer shown in the above formula is 1 is a hydrogen atom (H) or a methyl group (CH3). 2 is a linear, branched or cyclic hydrocarbon group having 1 to 20 carbon atoms (C1-20). 2 For example, an alkyl (meth)acrylate having an alkyl group of C1 to 12, typically C1 to 10, preferably C2 to 8, for example C3 to 5. As such an alkyl (meth)acrylate, for example, methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, n-butyl (meth)acrylate, tert-butyl (meth)acrylate, isobutyl (meth)acrylate, n-pentyl (meth)acrylate, tert-pentyl (meth)acrylate, hexyl (meth)acrylate, 2-methylbutyl (meth)acrylate, heptyl (meth)acrylate, octyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, nonyl (meth)acrylate, decyl (meth)acrylate, dodecyl (meth)acrylate, stearyl (meth)acrylate, cyclopentyl (meth)acrylate, cyclohexyl (meth)acrylate and the like linear, branched and cyclic alkyl (meth)acrylates can be specifically mentioned. These alkyl (meth)acrylates can be contained alone or in combination of two or more.
[0064] Excessive inclusion of the (meth)acrylic acid alkyl ester component may damage the balance of the above-mentioned polymer components (A) to (C), and is therefore not preferred. Therefore, when the (meth)acrylic acid alkyl ester component is contained, it is considered appropriate to contain it in a ratio of about 10 parts by mass when the total amount of the polymer components is 100 parts by mass. The ratio of the (meth)acrylic acid alkyl ester component is typically about 5 parts by mass or less, for example, 3 parts by mass or less, 1 part by mass or less, for example, a configuration in which it is substantially free of the component.
[0065] In addition, as other polymer components, an ultraviolet absorbing monomer component having ultraviolet absorbing ability and copolymerizable with the above-mentioned polymer components (A) to (D) can be contained. The lens has the property of being difficult to transmit ultraviolet rays, while the soft intraocular lens can transmit ultraviolet rays, so there is a risk of damaging the retina. For this reason, by containing an ultraviolet absorbing monomer component having ultraviolet absorbing ability as a secondary monomer component, the (meth) acrylate copolymer constituting the soft intraocular lens 1 can be given ultraviolet absorbing ability. As a result, retinal damage can be suppressed, and the risk of eye diseases caused by ultraviolet rays such as macular degeneration and keratitis can be reduced. Among them, "ultraviolet absorbing monomer" refers to all monomers containing a functional group having ultraviolet absorbing ability. In addition, as a functional group having ultraviolet absorbing ability, it means a group of functional atomic groups having an absorption spectrum in the ultraviolet region. Such a functional group having ultraviolet absorbing ability can be a general term for alkyl residues, carboxylic acid residues, alcohol residues, amino residues, acyl groups, etc. of ultraviolet absorbing compounds widely used as ultraviolet absorbers. In one example, the UV absorbing functional group widely includes an atomic group obtained by removing a hydrogen atom from a carboxyl group, a hydroxyl group, an amino group, etc. in the UV absorbing compound, or an acyl group in the UV absorbing compound. More specifically, as the UV absorbing monomer component, a benzotriazole monomer component, a benzophenone monomer component, a salicylic acid monomer component, and a cyanoacrylate monomer component can be preferably used.
[0066] Regarding the ultraviolet absorbing monomer component, it is considered appropriate to contain it in a ratio of about 0.1 to 1 part by mass when the total amount of the polymerized components is 100 parts by mass. This is because, when the ratio of the ultraviolet absorbing monomer component is less than 0.1% by mass, the ultraviolet absorption ability of the soft intraocular lens 1 becomes too low, and there is a possibility that it cannot function effectively. In addition, when the ratio of the ultraviolet absorbing monomer component is too high compared to 1% by mass, there is a possibility that the soft intraocular lens 1 will change color due to changes in physical properties or changes over time. The ratio of the ultraviolet absorbing monomer component is typically about 0.15 to 0.7% by mass, for example, more preferably about 0.2 to 0.5% by mass.
[0067] In addition, since the lens is slightly yellow, it has the property of partially inhibiting the transmission of blue light, which is its complementary color. Therefore, for the (meth)acrylate copolymer disclosed herein, it is also preferred to use yellow pigments, red pigments, etc. to color it and adjust the color vision. As such a colorant, azo compounds and pyrazole compounds that are copolymerizable with the above-mentioned (meth)acrylate monomer components and used as colorants for such soft intraocular lenses can be appropriately used. These can be appropriately determined in terms of their amount in relation to the above-mentioned polymer components. For example, it can be contained in a range of about 0.001 to 0.1 parts by mass relative to 100 parts by mass of the polymer component.
[0068] As other compounds used to constitute the (meth)acrylate copolymer, for example, polymerization initiators can be cited. As polymerization initiators, for example, free radical polymerization initiators including benzoin ethers and amines can be preferably used. As an example, polymerization initiators represented by 2,2-azobisisobutyronitrile, azobis(dimethylvaleronitrile), benzoin, methyl o-benzoylbenzoate, etc. can be used. These can be appropriately determined in amount according to the relationship with the above-mentioned polymerization components. For example, relative to 100 parts by mass of the polymerization component, it can be contained in a range of about 0.01 to 1 part by mass.
[0069] The method for obtaining the soft intraocular lens material is not particularly limited, and various polymerization methods known as the synthesis methods of the known (meth) acrylate copolymers such as solution polymerization, emulsion polymerization, bulk polymerization, suspension polymerization, and photopolymerization can be appropriately used. Among them, for example, a solution polymerization method in which a mixed monomer composition appropriately blended with the above-mentioned polymerization components is polymerized can be preferably used. In addition, when manufacturing the soft intraocular lens 1, a conventionally known manufacturing method such as the so-called cast molding method and lathe cutting method can be appropriately used. For example, in the cast molding method, specifically, a casting mold having a cavity (void) corresponding to the shape of the target soft intraocular lens 1 can be prepared, and a raw material composition (raw material monomer solution) can be supplied to the casting mold, and the raw material composition can be polymerized in the casting mold. For example, in the cutting method, specifically, a mixed monomer composition corresponding to the composition of the target soft intraocular lens 1 can be polymerized into a sheet (including a plate, etc.), and the polymerized sheet-shaped soft intraocular lens material can be cut to be processed into a soft intraocular lens of a desired shape. During cutting, the sheet-shaped soft intraocular lens material can be frozen.
[0070] The soft intraocular lens material disclosed herein significantly reduces the occurrence of flare. For example, when flare is artificially generated, the number and area of bright spots observed under a microscope are reduced. For example, as a condition for artificially generating flare, the temperature can be changed from 25°C to 60°C after being kept in a wet state.
[0071] The so-called wet state can be grasped as a state in which the soft intraocular lens material is immersed in pure water, for example. By immersing the soft intraocular lens material in pure water instead of physiological saline, etc., flare can be generated in a shorter time. In this specification, as pure water, ultrapure water with a resistivity of 15MΩ·cm or more or a conductivity of 0.058μS / cm or less at 25°C is preferably used. The retention time of the lens material in a high temperature environment of 60°C can be, for example, based on about 2 hours. Thereby, water can be fully absorbed in a state in which the polymer structure of the lens material is relaxed. In other words, the lens material can be made to absorb water supersaturatedly.
[0072] After that, the temperature of the soft intraocular lens material is changed (cooled) to 25°C. This can shrink the polymer structure of the lens material (reduce the water absorption rate), and the water remaining in the polymer structure can be condensed in the tiny gaps under room temperature. In order to stabilize the polymer structure and the state of flare generation after cooling, the cooled lens material can be kept at 25°C for about 24 hours. This can promote the generation of flare.
[0073] In addition, a variation or error of about ±2° C. is allowed for the temperatures of “60° C.” and “25° C.” as the temperature conditions for generating flare described above.
[0074] At this time, in the conventional soft intraocular lens material, it is confirmed that the entire lens material becomes cloudy or that conspicuous bright spots appear in the entire lens material. For the conventional soft intraocular lens material, the number of bright spots confirmed by microscopic observation can reach 1000 / mm per unit area. 2 In addition, for example, the area of flare confirmed in a lens material with a diameter of about 6 mm can exceed 0.05 mm. 2 In contrast, the soft intraocular lens material disclosed herein, in addition to the hydrophilic acrylate, the combination of the aromatic ring-containing methacrylate (A) and the alkoxy-containing acrylate (B) also well suppresses flare. As a result, the number of bright spots of flare per unit area observed under a microscope was suppressed to 400 / mm 2 In addition, for example, the area of flare confirmed in a lens material with a diameter of about 6 mm can be as small as 0.05 mm. 2 Below (for example, 0.045 mm 2 Below, further 0.043mm 2 the following).
[0075] Furthermore, the international rubber hardness of the soft intraocular lens material disclosed herein can be adjusted to an appropriate softness that is neither too soft nor too hard, that is, 40 or more and 60 or less, which is most suitable for folding the lens. Such appropriate softness is also achieved by an appropriate combination of the aromatic ring-containing methacrylate (A) and the alkoxy group-containing acrylate (B). Therefore, the soft intraocular lens material disclosed herein can be said to be a novel soft intraocular lens material that maintains appropriate softness and suppresses the occurrence of flare, and that has both softness and anti-flare properties.
[0076] In addition, the soft intraocular lens 1 disclosed herein is composed of the (meth)acrylate copolymer having the above-mentioned structure, and therefore can have the flexibility and elastic restoring force suitable for folding, similar to the existing soft intraocular lenses. In addition, the soft intraocular lens 1 disclosed herein also reduces the occurrence of flare. Therefore, it can be said that the soft intraocular lens 1 has excellent affinity in the biological environment. Moreover, even if the soft intraocular lens 1 is folded smaller, it can be immediately unfolded and restored to its original shape when the folding force is released. Therefore, the soft intraocular lens 1 disclosed herein is particularly suitable for use as a soft intraocular lens in a form that is bent smaller using a special insertion instrument and inserted into the eye. From this point of view, the technology disclosed herein can preferably provide the intraocular lens insertion system.
[0077] Specifically, although not shown, the intraocular lens insertion system includes the soft intraocular lens 1 and an inserter. The inserter has, for example, a syringe-type inserter body and a plunger. On the front end side of the inserter body, the width of the internal space is reduced, and the soft intraocular lens 1 is configured to pass through the internal space and fold smaller in the width direction. The soft intraocular lens 1 is pre-set in the interior of the inserter body in a flat state. When the soft intraocular lens 1 is inserted into the capsule, etc., a lubricant including a viscoelastic substance or the like is supplied to the inserter body, and then the plunger is pushed into the inserter body. As a result, the soft intraocular lens 1 is bent to be folded, and the soft intraocular lens 1 is discharged to the outside from the discharge port at the front end of the inserter together with the lubricant. As a result, the soft intraocular lens 1 can be easily inserted into the lens capsule of the eyeball. In addition, the inserter can also be composed of only a cartridge portion of the inserter body, which is a portion from a storage portion for storing the soft intraocular lens 1 to a discharge port for discharging the soft intraocular lens 1. For example, the column portion may be configured to be attachable to and detachable from the inserter body.
[0078] Example
[0079] Several embodiments of the present invention will be described below, but the present invention is not limited to these specific examples.
[0080] As polymerizable components, the following polymerizable monomers were prepared in the ratio shown in Table 1, and a polymerization initiator was added and uniformly mixed to prepare raw material compositions for intraocular lenses of Examples 1 to 19 and Comparative Examples 1 to 13. In addition, the raw material compositions of Examples 11 to 13 and Comparative Examples 11 and 13 contained two kinds of alkoxy-containing acrylates (B), but the raw material compositions of other examples contained one kind each of aromatic ring-containing methacrylate (A), alkoxy-containing acrylate (B), hydrophilic monomer (C), and crosslinking monomer (D). Thereafter, the raw material compositions were poured into a biconvex lens type casting mold with a column and a mold frame (flat plate), and polymerized at 60°C for 12 hours and 100°C for 12 hours. Thus, first, a soft lens molded body for flare evaluation of each example was obtained. Furthermore, the flat polymer was cut into 1.5 cm squares with a thickness of 1 mm to prepare intraocular lens materials for international rubber hardness evaluation of each example.
[0081] The following six types of aromatic ring-containing monomers were prepared.
[0082] BZMA: Benzyl Methacrylate
[0083] EGPEMA: Ethylene glycol monophenyl ether methacrylate
[0084] EGPEA: Ethylene glycol monophenyl ether acrylate
[0085] PEMA: Phenyl ethyl methacrylate
[0086] PEA: Phenyl Ethyl Acrylate
[0087] The following seven monomers were prepared as monomers not containing an aromatic ring.
[0088] MEA: 2-methoxyethyl acrylate
[0089] EEEA: 2-(2-ethoxyethoxy)ethyl acrylate
[0090] MEMA: 2-methoxyethyl methacrylate
[0091] EEMA: 2-ethoxyethyl methacrylate
[0092] EA: Ethyl acrylate
[0093] BA: n-butyl acrylate
[0094] BMA: n-butyl methacrylate
[0095] As the hydrophilic monomers, the following three types were prepared.
[0096] HBA: 4-Hydroxybutyl Acrylate
[0097] HEA: 2-Hydroxyethyl Acrylate
[0098] HEMA: 2-Hydroxyethyl Methacrylate
[0099] The following three types were prepared as crosslinkable monomers.
[0100] BDDA: 1,4-Butanediol diacrylate
[0101] NDDA: 1,9-nonanediol diacrylate
[0102] TMPTA: Trimethylolpropane triacrylate
[0103] [Measurement of IRHD]
[0104] The international rubber hardness (IRHD) was measured for the intraocular lens material (1.5 cm square) used for evaluation in each example. As a hardness tester, GS-680sel (Type A hardness tester specified in JIS K6253:2012) manufactured by TECLOCK Co., Ltd. was used, and the plane hardness was measured in accordance with the M method (micro-size test for medium hardness) of ISO48:2010 (JIS K6253-2). The international rubber hardness was measured by acclimating the soft lens molding of each example to a test environment of temperature: 21 to 23°C and humidity: 30 to 70% RH for more than 1 hour, and then measuring the rubber hardness with a test number: n=5. The arithmetic mean was calculated from the obtained international rubber hardness and is shown in the corresponding column of the following Table 1. In addition, the lower limit of IRHD is "30", and the hardness with an IRHD lower than 30 cannot be measured.
[0105] [Evaluation of flare suppression]
[0106] After promoting flare in the soft lens molded bodies used for evaluation of each example, the number and area of bright spots of flare were calculated by microscopic observation and image analysis to evaluate the flare characteristics. In the soft lens molded bodies, the diameter of the optical part is about 6 mm and the thickness is 0.6 mm, and a pair of support parts are provided at its periphery. The promoting conditions for producing flare are as follows: the soft lens molded bodies of each example are immersed in ultrapure water, kept in a heated environment of 60°C for 2 hours, and then left to stand at room temperature for 24 hours. This is to give the lens molded body a drastic temperature change from high temperature to low temperature in a humid environment simulated in a capsule, thereby causing the water absorption rate of the lens molded body to suddenly decrease, creating a situation where water remains locally in the polymer structure. As ultrapure water, ultrapure water (usually 18 MΩ·cm or more) with a resistivity managed at 16 MΩ·cm or more (25°C) is used. Among them, the room temperature environment is managed at 25±2°C.
[0107] For microscopic observation, a stereoscopic microscope SMZ1500 manufactured by Nikon Corporation and a digital camera DS-Vi1 manufactured by Nikon Corporation were used, and these were controlled using the image integration software NIS-Elements to obtain a planar image (800×600 pixels) of the soft lens molding for evaluation. In the image, the curved portion of the support portion of the soft lens molding is arranged at the diagonal position, and the observation field is set in such a way that the optical portion is arranged larger on the entire surface of the image. Image analysis was performed using Image J developed by the National Institutes of Health (NIH).
[0108] The observation conditions of the stereomicroscope are as follows.
[0109] Mode setting: Manual exposure
[0110] Exposure time: 30m / s
[0111] Gain: 1.00×
[0112] Contrast setting: Standard
[0113] Lighting: Dark field (maximum light)
[0114] Dimming dial: Maximum light
[0115] Magnification: 15x (objective lens 1x, eyepiece 10x, magnification 1.5x)
[0116] The number of bright spots and the area of the bright spots are calculated by the following operation using image analysis.
[0117] First, import the plane image of the soft lens molding body taken into Image J, and convert the image into 8-bit grayscale by implementing the "8-bit" processing in the Type submenu of the Image menu. Then, in the Adjust submenu, adjust the upper limit of the Threshold level to 255 and the lower limit to 40, thereby converting the pixels within the threshold range of the image to black and the pixels outside it to white. As a result, the image of the soft lens molding body is roughly binarized, with the outline and bright spots in black and the other parts in white. Then, use the elliptical area selection tool button in the Image menu to select the area of the optical part of the binarized soft lens molding image (inside the outline) to create an analysis area (Create Selection).
[0118] Next, use the Analyze Particles submenu of the Analyze menu to measure the number and area of objects (black dots representing bright spots) in the selected area. The particle count calculated by this submenu is set as the number of bright spots, and the total particle area is set as the total area of bright spots.
[0119] Then, the flare suppression effect was evaluated based on the number and area of the obtained bright spots according to the indexes shown in Table 2 below, and the results are shown in the "Sensory Evaluation" column of Table 2. In addition, since the total area of the particles is expressed in pixels, the total area was converted to mm based on the relationship of 1 mm = about 96 pixels obtained from the magnification of the image. 2 For reference, the calculation results of the total area are shown in Table 1.
[0120] [evaluate]
[0121] From the above evaluation results of IRHD and flare suppression, it can be seen that a soft intraocular lens material with an IRHD of 40 to 60 and an A in the functional evaluation of flare is evaluated as a good product (OK) having appropriate mechanical properties such as flexibility and a flare suppression effect, while a soft intraocular lens material with an IRHD of less than 40 or more than 60, or a B or C in the functional evaluation of flare is evaluated as a defective product (NG). The results are shown in the "Evaluation" column of Table 1.
[0122] [Table 1]
[0123]
[0124] [Table 2]
[0125] Table 2
[0126]
[0127] As shown in Table 1, Examples 1 to 10 are examples in which BZMA as a methacrylic monomer containing an aromatic ring, MEA as an acrylic monomer containing no aromatic ring and alkoxy group, HBA as a hydrophilic acrylic monomer, and BDDA as a crosslinking acrylic monomer are combined and used with various changes in their proportions. It was confirmed that a soft intraocular lens material having both appropriate physical properties and flare suppression effects can be obtained by such a combination of monomers. It was also confirmed that, among the main polymer components, the main component (largest component) can achieve good properties regardless of whether BZMA as a monomer containing an aromatic ring or MEA as a monomer containing no aromatic ring. Moreover, for example, from the comparison of Examples 6 to 8, it can be seen that in a system in which the main polymer components are a methacrylic monomer containing an aromatic ring and an acrylic monomer containing no aromatic ring and alkoxy group, it is confirmed that flare is not necessarily reduced as the content of the hydrophilic monomer increases. It can be seen from this that an appropriate combination of an aromatic ring-containing methacrylic monomer and an aromatic ring-free and alkoxy-containing acrylic monomer also contributes to the reduction of flare.
[0128] However, as shown in Comparative Example 1, it was confirmed that when the total amount of the polymer components was 100 parts by mass, if the acrylic monomer MEA in the main polymer component was less than 30 parts by mass, the IRHD exceeded 60, and the polymer was sometimes too hard. It can be said that it is preferable that the softer acrylic component account for 30 parts by mass or more in the main polymer component.
[0129] On the other hand, HBA used as the hydrophilic monomer was changed to HEA in Example 11 and to HEMA in Comparative Example 2. It is known that in Example 11, HEA, which is an acrylic monomer component like HBA, was used as the hydrophilic monomer, and a soft intraocular lens material having both appropriate softness and flare suppression effect was obtained as in Examples 1 to 10. However, in Comparative Example 2, HEMA, a methacrylic monomer component, was used as the hydrophilic monomer, and flare was abnormally generated. It is believed that this is because the hydrophilic methacrylic monomer component exists on the surface of the polymer, so that the hydrophobic surface cannot be properly formed by BZMA, and flare cannot be well suppressed. It is known that in a system in which an aromatic ring-containing methacrylic monomer and an alkoxy-containing acrylic monomer that does not contain an aromatic ring are used as the main and secondary synthetic components, when a methacrylic monomer is mixed as a hydrophilic monomer, the occurrence of flare cannot be properly suppressed.
[0130] In addition, as a crosslinking monomer, NDDA with a large number of carbon atoms was used in Example 12, and trifunctional TMPTA was used in Example 13, instead of BDDA with a small number of carbon atoms and a bifunctional group. As for the crosslinking monomer, even when the number of functional groups, the length of the monomer chain, etc. were changed, the flexibility and flare suppression effect of the soft intraocular lens material did not change significantly. It can be seen that there is no particular limitation on the type of the crosslinking monomer, and various crosslinking monomers can be used in combination with the above-mentioned polymerizable monomers.
[0131] In Example 14 and Comparative Examples 3 to 6, EEEA, which is also an acrylic monomer containing no aromatic ring and containing alkoxy groups, was used in Example 14 instead of MEA, which is an acrylic monomer containing no aromatic ring and containing alkoxy groups, MEMA and EEMA, which are also methacrylates, were used in Comparative Examples 3 to 4, and BA and BMA, which are (meth)acrylate monomers containing alkyl groups, were used in Comparative Examples 5 to 6. It is understood that in Example 14, which uses EEEA, which is an alkoxyacrylate monomer component like MEA, a soft intraocular lens material having both appropriate flexibility and flare suppression effect was obtained in the same manner as in Examples 1 to 10. However, in Comparative Examples 3 and 4, which use alkoxymethacrylate monomers MEMA and EEMA as a substitute for the alkoxyacrylate monomer, and in Comparative Example 6, which uses BMA, which is an alkylmethacrylate monomer, it was confirmed that IRHD increased significantly and the soft intraocular lens material lost flexibility. On the other hand, in Comparative Example 5, which uses an alkylacrylate monomer, the flexibility was good, but the occurrence of flare could not be suppressed appropriately.
[0132] Furthermore, as shown in Examples 15 to 17, it was confirmed that the same effect can be obtained even if two or more different monomer components such as MEA and EEEA are used simultaneously as long as the acrylic monomer does not contain an aromatic ring and contains an alkoxy group.
[0133] From these results, it can be confirmed that whether the monomer component is acrylate or methacrylate has a significant influence on the physical properties and flare properties of the formed polymer.
[0134] Subsequently, in Examples 18 to 19 and Comparative Examples 7 to 8, instead of the aromatic ring-containing methacrylate BZMA, EGPEMA and EGPEA were used in Example 18 and Comparative Example 7, and PEMA and PEA were used in Example 19 and Comparative Example 8, respectively. It was found that in Examples 18 to 19 using the aromatic ring-containing methacrylate EGPEMA or PEMA, a soft intraocular lens material having both excellent physical properties and flare suppression effect was obtained. However, in Comparative Examples 7 to 8 using these acrylates EGPEA and PEA, the obtained polymer became too soft and IRHD could not be measured. It was found that when the aromatic ring-containing monomer combined with the alkoxy-containing acrylic monomer not containing an aromatic ring is not a methacrylic monomer, the handling of the soft intraocular lens material becomes difficult.
[0135] As described above, it can be seen that the properties of the obtained soft intraocular lens material vary greatly depending on whether each monomer component is an acrylate monomer or a methacrylate monomer. Among them, in Comparative Examples 9 to 13, the combination of acrylate and methacrylate of the aromatic ring-containing monomer, the non-aromatic ring-free monomer, the hydrophilic monomer, and the crosslinking monomer was changed in various ways. As a result, it was confirmed that, for example, when EGPEA was used as the aromatic ring-containing monomer, as shown in Comparative Examples 9 to 11 and 13, IRHD was likely to be as low as 40 regardless of whether EA, EEMA, or any of these combinations was used as the non-aromatic ring-free monomer. Although the soft intraocular lens has high flexibility, there is a concern that it takes time for the folded lens to restore its shape in the capsule, or that the shape cannot be fully restored. At the same time, there is also a concern that the lens is easily damaged when injected from the inserter. In addition, regarding the soft intraocular lens of Comparative Example 12, although the IRHD is 40 and is suitable, it is easy to produce flare, and it is not possible to achieve both physical properties and low flare properties. From the above results, it can be seen that even if there is a small difference in the combination of the monomers used, the balance of the IRHD and / or flare suppression effect is lost, and a high-quality soft intraocular lens material cannot be provided. From these results, it can be confirmed that it is important for the technology disclosed herein to combine a methacrylic monomer containing an aromatic ring, an acrylic monomer containing no aromatic ring and an alkoxy group, and a hydrophilic acrylic monomer to form a soft intraocular lens material.
[0136] The specific examples of the present invention have been described in detail above, but these are only examples and do not limit the scope of the patent claims. The technology described in the scope of the patent claims includes various modifications and changes to the specific examples illustrated above.
Claims
1. A soft intraocular lens material, characterized in that: It is a soft intraocular lens material made of polymerizable components. The polymeric component comprises: Aromatic ring-containing methacrylate (A), Alkyloxy-containing acrylate (B), Hydroxyl-containing acrylate (C), Crosslinkable (meth)acrylate (D), and Alkyl (meth)acrylate (E), The ratio of the alkyl (meth)acrylate (E) is 5 parts by mass or less based on 100 parts by mass of the polymer component. When the total amount of the four polymer components (A) to (D) is 100 parts by mass, The aromatic ring-containing methacrylate (A) is in an amount of 40 parts by mass or more and 55 parts by mass or less, The alkoxy-containing acrylate (B) is in an amount of 30 parts by mass or more and 46 parts by mass or less, The hydroxyl-containing acrylate (C) is in an amount of 8 parts by mass or more and 12 parts by mass or less, The ratio of the cross-linkable (meth)acrylate (D) is 1 part by mass or more and 10 parts by mass or less.
2. The soft intraocular lens material according to claim 1, wherein: When the total of the four polymerization components (A) to (D) is 100 parts by mass, the amount of the aromatic ring-containing methacrylate (A) is 40 parts by mass or more and 52 parts by mass or less.
3. The soft intraocular lens material according to claim 1 or 2, wherein: When the total of the four polymerization components (A) to (D) is 100 parts by mass, the amount of the alkoxy-containing acrylate (B) is 35 parts by mass or more and 46 parts by mass or less.
4. The soft intraocular lens material according to claim 1 or 2, wherein: When the total of the four polymerization components (A) to (D) is 100 parts by mass, the amount of the hydroxyl group-containing acrylate (C) is 9 parts by mass or more and 11.5 parts by mass or less.
5. The soft intraocular lens material according to claim 1 or 2, wherein: The total amount of the aromatic ring-containing methacrylate (A) and the alkoxy group-containing acrylate (B) is 75 parts by mass or more and 90 parts by mass or less based on 100 parts by mass of the polymerization component.
6. The soft intraocular lens material according to claim 1 or 2, wherein: The aromatic ring-containing methacrylate (A) contains a methacrylate represented by the following general formula (1): In the formula, R1 is a linear or branched alkylene group having 1 to 2 carbon atoms, and X represents an absent element or an oxygen atom.
7. The soft intraocular lens material according to claim 6, wherein: The alkoxy-containing acrylate (B) contains an acrylate represented by the following general formula (2): Wherein, in the formula, R2 is a methyl group or an ethyl group, and n is an integer of 1 to 2.
8. The soft intraocular lens material according to claim 7, wherein: The hydroxyl-containing acrylate (C) contains an acrylate represented by the following general formula (3): In the formula, R3 is a linear or branched alkylene group having 1 to 8 carbon atoms.
9. The soft intraocular lens material according to claim 8, wherein: The crosslinkable (meth)acrylate (D) includes a bifunctional (meth)acrylate or a trifunctional (meth)acrylate.
10. The soft intraocular lens material according to claim 9, wherein: The alkyl (meth)acrylate (E) includes octyl (meth)acrylate.
11. The soft intraocular lens material according to claim 1 or 2, wherein: The polymer component includes a monomer having ultraviolet absorbing ability.
12. The soft intraocular lens material according to claim 1 or 2, wherein: The polymeric component comprises a monomer having yellow coloring capability.
13. A soft intraocular lens, characterized in that: This is a soft intraocular lens produced using the intraocular lens material according to any one of claims 1 to 12.
